Advocacy
For most of its history, since the first cord blood transplant in the late 1980s and the founding of the first cord blood bank in the early 1990s, there has been no industry-wide organization or voice for the cord blood community. Advocacy has been left to individual banks, registries, physician organizations and patient groups – each with its own perspective and sometimes distracting interests. That’s worked to a degree. But the need for an organization precisely focused on cord blood was recognized overwhelmingly by industry representatives gathered for a global conference in 2014. The CBA, its structure, governance and programs, was created to fulfill that need. The CBA is the new force for the cord blood community in government affairs and health professional and public education.
Recent NewsCBA Foundation Directors Review Recent Projects National Cord Blood Inventory Re-Authorized through FY2025 E.U. Begins Blood, Tissue and Cell Regulations Update COVID-19: Cord Blood Inventories Safe and Readily Available Model Criteria Adopted for Banking Laws and Regulations Busting Cord Blood Myths with Facts Top Ten Essentials for Cord Blood Banking Comparison of Cord Blood Banking Standards and Voluntary Accreditations CBA Seeks Harmony for Rules and Regulations Statement on Delayed Umbilical Cord Clamping Guidelines for Zika Virus Screening CBA Board Approves 32 Policy Statements Vigilance Encouraged for Ebola Virus Safety U.S. Congress Approves Stem Cell Act Reauthorization Cord Blood Association Retains Sidley Austin
|
The CBA has five priorities, none more important than advocacy. The association is representing the interests of the cord blood community in: